Biomarin Pharmaceutical Inc

Rhenman & Partners Asset Management AB BMRN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

215,000

Value ($000)

12,777

Weight

1.2%

2013 Q4 - 2025 Q4 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	12,777	1.2%	215,000	12/31/2025
2025 Q3	11/13/2025	10,109	1.1%	186,650	9/30/2025
2025 Q2	8/13/2025	8,226	1.0%	149,650	6/30/2025
2014 Q2	7/31/2014	9,332	2.8%	150,000	6/30/2014
2014 Q1	5/14/2014	9,908	3.0%	145,264	3/31/2014
2013 Q4	2/14/2014	7,027	2.8%	100,000	12/31/2013